The two faces of Interleukin-17A in atherosclerosis
A complex network of different cytokines and chemokines modulates atherosclerosis, a chronic inflammatory disease. Interleukin-17A (IL-17A) is expressed by different leukocyte subsets such as CD4+IL-17+ T cells (Th17), γδ T cells, natural killer cells, natural killer T cells, and neutrophils. IL-17A...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2017
|
| In: |
Current drug targets
Year: 2017, Jahrgang: 18, Heft: 7, Pages: 863-873 |
| ISSN: | 1873-5592 |
| DOI: | 10.2174/1389450117666161229142155 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.2174/1389450117666161229142155
|
| Verfasserangaben: | Mohammadreza Akhavanpoor, Hamidreza Akhavanpoor, Christian A. Gleissner, Susanne Wangler, Andreas O. Doesch, Hugo A. Katus, and Christian Erbel |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 157182328X | ||
| 003 | DE-627 | ||
| 005 | 20230426124235.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180409s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1389450117666161229142155 |2 doi | |
| 035 | |a (DE-627)157182328X | ||
| 035 | |a (DE-576)50182328X | ||
| 035 | |a (DE-599)BSZ50182328X | ||
| 035 | |a (OCoLC)1341001910 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Akhavanpoor, Mohammadreza |d 1982- |e VerfasserIn |0 (DE-588)1022954121 |0 (DE-627)717338517 |0 (DE-576)366213652 |4 aut | |
| 245 | 1 | 4 | |a The two faces of Interleukin-17A in atherosclerosis |c Mohammadreza Akhavanpoor, Hamidreza Akhavanpoor, Christian A. Gleissner, Susanne Wangler, Andreas O. Doesch, Hugo A. Katus, and Christian Erbel |
| 264 | 1 | |c 2017 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 09.04.2018 | ||
| 520 | |a A complex network of different cytokines and chemokines modulates atherosclerosis, a chronic inflammatory disease. Interleukin-17A (IL-17A) is expressed by different leukocyte subsets such as CD4+IL-17+ T cells (Th17), γδ T cells, natural killer cells, natural killer T cells, and neutrophils. IL-17A plays an important role in host defense and is involved in the pathology of different autoimmune and inflammatory diseases. Recent studies demonstrate an association of IL-17A with atherosclerosis. IL-17A seems to have primarily pro-inflammatory effects in atherogenesis, although there are partially controversial results in the literature. In the murine system, several studies indicate a pro-atherogenic role of IL-17A mediated by increased migration of leukocytes (especially macrophages) into atherosclerotic lesions, increased expression of pro-inflammatory cytokines and chemokines as well as plaque destabilizing matrix-metalloproteinases using Apoe-/- and LDLr-/- mice. In contrast, three studies show atheroprotective effects of IL-17A mediated by downregulation of aortic VCAM-1 expression on endothelial cells and increased collagen production by vascular smooth muscle cells (VSMCs) in LDLr-/- mice. In humans, expression of IL-17A was associated with increased inflammation and plaque vulnerability in human atherosclerotic lesions. Moreover, IL-17A induced a pro-inflammatory, pro-thrombotic, plaque-destabilizing, and cell-attracting response of the inflammatory milieu of human plaque tissue samples. Notably, a recently published study challenged these findings by showing a worse outcome of patients with acute myocardial infarction with low serum levels of IL-17A. In the following review, we will focus on the recent progress of functional studies of IL-17A in atherosclerosis and will try to collect explanations for the controversial data. | ||
| 650 | 4 | |a anti-atherogenic | |
| 650 | 4 | |a atherosclerosis | |
| 650 | 4 | |a inflammation | |
| 650 | 4 | |a Interleukin-17A | |
| 650 | 4 | |a plaque vulnerability | |
| 650 | 4 | |a pro-atherogenic | |
| 700 | 1 | |a Akhavanpoor, Hamidreza |e VerfasserIn |0 (DE-588)1155741048 |0 (DE-627)1017946752 |0 (DE-576)501823999 |4 aut | |
| 700 | 1 | |a Gleißner, Christian A. |d 1976- |e VerfasserIn |0 (DE-588)124269907 |0 (DE-627)085750522 |0 (DE-576)294095578 |4 aut | |
| 700 | 1 | |a Wangler, Susanne |d 1979- |e VerfasserIn |0 (DE-588)1025190165 |0 (DE-627)721542093 |0 (DE-576)370056469 |4 aut | |
| 700 | 1 | |a Dösch, Andreas |d 1976- |e VerfasserIn |0 (DE-588)129172758 |0 (DE-627)390355798 |0 (DE-576)297522310 |4 aut | |
| 700 | 1 | |a Katus, Hugo |d 1951- |e VerfasserIn |0 (DE-588)108916618 |0 (DE-627)577155040 |0 (DE-576)289625076 |4 aut | |
| 700 | 1 | |a Erbel, Christian |d 1976- |e VerfasserIn |0 (DE-588)132600927 |0 (DE-627)524413401 |0 (DE-576)299249603 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current drug targets |d Hilversum : Bentham Science Publ., 2000 |g 18(2017), 7, Seite 863-873 |h Online-Ressource |w (DE-627)327962399 |w (DE-600)2044606-8 |w (DE-576)273880896 |x 1873-5592 |7 nnas |a The two faces of Interleukin-17A in atherosclerosis |
| 773 | 1 | 8 | |g volume:18 |g year:2017 |g number:7 |g pages:863-873 |g extent:11 |a The two faces of Interleukin-17A in atherosclerosis |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/1389450117666161229142155 |x Verlag |x Resolving-System |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180409 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 132600927 |a Erbel, Christian |m 132600927:Erbel, Christian |d 910000 |d 910100 |e 910000PE132600927 |e 910100PE132600927 |k 0/910000/ |k 1/910000/910100/ |p 7 |y j | ||
| 998 | |g 108916618 |a Katus, Hugo |m 108916618:Katus, Hugo |d 910000 |d 910100 |e 910000PK108916618 |e 910100PK108916618 |k 0/910000/ |k 1/910000/910100/ |p 6 | ||
| 998 | |g 129172758 |a Dösch, Andreas |m 129172758:Dösch, Andreas |d 910000 |d 910100 |e 910000PD129172758 |e 910100PD129172758 |k 0/910000/ |k 1/910000/910100/ |p 5 | ||
| 998 | |g 1025190165 |a Wangler, Susanne |m 1025190165:Wangler, Susanne |d 910000 |d 910100 |e 910000PW1025190165 |e 910100PW1025190165 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 998 | |g 124269907 |a Gleißner, Christian A. |m 124269907:Gleißner, Christian A. |d 910000 |d 910100 |e 910000PG124269907 |e 910100PG124269907 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 1155741048 |a Akhavanpoor, Hamidreza |m 1155741048:Akhavanpoor, Hamidreza |p 2 | ||
| 998 | |g 1022954121 |a Akhavanpoor, Mohammadreza |m 1022954121:Akhavanpoor, Mohammadreza |d 910000 |d 910100 |e 910000PA1022954121 |e 910100PA1022954121 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN157182328X |e 3005372537 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"name":{"displayForm":["Mohammadreza Akhavanpoor, Hamidreza Akhavanpoor, Christian A. Gleissner, Susanne Wangler, Andreas O. Doesch, Hugo A. Katus, and Christian Erbel"]},"note":["Gesehen am 09.04.2018"],"recId":"157182328X","person":[{"given":"Mohammadreza","display":"Akhavanpoor, Mohammadreza","role":"aut","family":"Akhavanpoor"},{"display":"Akhavanpoor, Hamidreza","given":"Hamidreza","role":"aut","family":"Akhavanpoor"},{"family":"Gleißner","role":"aut","display":"Gleißner, Christian A.","given":"Christian A."},{"role":"aut","family":"Wangler","given":"Susanne","display":"Wangler, Susanne"},{"display":"Dösch, Andreas","given":"Andreas","family":"Dösch","role":"aut"},{"given":"Hugo","display":"Katus, Hugo","role":"aut","family":"Katus"},{"family":"Erbel","role":"aut","given":"Christian","display":"Erbel, Christian"}],"physDesc":[{"extent":"11 S."}],"id":{"eki":["157182328X"],"doi":["10.2174/1389450117666161229142155"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"The two faces of Interleukin-17A in atherosclerosis","title_sort":"two faces of Interleukin-17A in atherosclerosis"}],"origin":[{"dateIssuedDisp":"2017","dateIssuedKey":"2017"}],"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"The two faces of Interleukin-17A in atherosclerosisCurrent drug targets","note":["Gesehen am 25.09.2017"],"pubHistory":["1.2000 -"],"language":["eng"],"part":{"year":"2017","volume":"18","issue":"7","pages":"863-873","extent":"11","text":"18(2017), 7, Seite 863-873"},"origin":[{"dateIssuedKey":"2000","publisherPlace":"Hilversum","publisher":"Bentham Science Publ.","dateIssuedDisp":"2000-"}],"title":[{"title":"Current drug targets","subtitle":"the international journal for timely in-depth reviews on drug targets","title_sort":"Current drug targets"}],"id":{"zdb":["2044606-8"],"eki":["327962399"],"issn":["1873-5592"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"327962399"}]} | ||
| SRT | |a AKHAVANPOOTWOFACESOF2017 | ||